Health Canada Recalls Hizentra Due to Appearance Issues
Health Canada has initiated a recall for Hizentra, an immune globulin product, after an affected lot displayed an out-of-specification appearance. This regulatory action aims to safeguard patient well-being for individuals using this particular health product.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.